BIOMAT Database Logo BIOMAT Database Logo

[Personal experience with replacement therapy with intravenous gamma globulin]. 1995

J Litzman, and J Lokaj, and D Stikarovská, and J Mayer, and V Thon, and M M Eibl
Ustav klinické imunologie LF Masarykovy univerzity, FN u sv. Anny, Brno.

Replacement therapy with intravenous immunoglobulin (IVIG) is currently the therapy of choice in patients with antibody-formation deficiency. Our 30-month experience with IVIG treatment in 8 patients with common variable immunodeficiency and in 4 patients with x-linked agammaglobulinemia previously treated by intramuscular immunoglobulin or low-dose IVIG is presented. Long-term dosage was 400 mg/kg once in 3--4 weeks. Ten patients reported an improvement of their health state, especially the signs of their chronic bronchitis improved. Compared to 2 cases of pneumonia which occurred within 30 months before IVIG therapy had started, no case of pneumonia occurred during IVIG treatment. Infusion rate of 4 mg/kg/min was safe enough in 11 of our patients. Serum trough IgG level is the most important for laboratory monitoring of the patients under IVIG therapy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000361 Agammaglobulinemia An immunologic deficiency state characterized by an extremely low level of generally all classes of gamma-globulin in the blood. Hypogammaglobulinemia,Agammaglobulinemias,Hypogammaglobulinemias
D016756 Immunoglobulins, Intravenous Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA. Antibodies, Intravenous,Human Intravenous Immunoglobulin,IV Immunoglobulin,IVIG,Intravenous Antibodies,Intravenous Immunoglobulin,Intravenous Immunoglobulins,Alphaglobin,Endobulin,Flebogamma DIF,Gamimmune,Gamimmune N,Gamimune,Gamimune N,Gammagard,Gammonativ,Gamunex,Globulin-N,IV Immunoglobulins,Immune Globulin Intravenous (Human),Immune Globulin, Intravenous,Immunoglobulins, Intravenous, Human,Intraglobin,Intraglobin F,Intravenous IG,Intravenous Immunoglobulins, Human,Iveegam,Modified Immune Globulin (Anti-Echovirus Antibody),Privigen,Sandoglobulin,Venimmune,Venoglobulin,Venoglobulin-I,Globulin N,Human Intravenous Immunoglobulins,Immunoglobulin, Human Intravenous,Immunoglobulin, IV,Immunoglobulin, Intravenous,Immunoglobulins, Human Intravenous,Immunoglobulins, IV,Intravenous Immune Globulin,Intravenous Immunoglobulin, Human,Venoglobulin I
D017074 Common Variable Immunodeficiency Heterogeneous group of immunodeficiency syndromes characterized by hypogammaglobulinemia of most isotypes, variable B-cell defects, and the presence of recurrent bacterial infections. Immunodeficiency, Common Variable,Common Variable Hypogammaglobulinemia,Common Variable Immune Deficiency,Hypogammaglobulinemia, Acquired,Immunoglobulin Deficiency, Late-Onset,Acquired Hypogammaglobulinemia,Acquired Hypogammaglobulinemias,Common Variable Hypogammaglobulinemias,Common Variable Immunodeficiencies,Deficiencies, Late-Onset Immunoglobulin,Deficiency, Late-Onset Immunoglobulin,Hypogammaglobulinemia, Common Variable,Hypogammaglobulinemias, Acquired,Hypogammaglobulinemias, Common Variable,Immunodeficiencies, Common Variable,Immunoglobulin Deficiencies, Late-Onset,Immunoglobulin Deficiency, Late Onset,Late-Onset Immunoglobulin Deficiencies,Late-Onset Immunoglobulin Deficiency,Variable Hypogammaglobulinemia, Common,Variable Hypogammaglobulinemias, Common

Related Publications

J Litzman, and J Lokaj, and D Stikarovská, and J Mayer, and V Thon, and M M Eibl
Intravenous therapy with gamma globulin.
January 1987, Advances in internal medicine,
J Litzman, and J Lokaj, and D Stikarovská, and J Mayer, and V Thon, and M M Eibl
Intravenous gamma globulin therapy.
April 1982, Journal of clinical immunology,
J Litzman, and J Lokaj, and D Stikarovská, and J Mayer, and V Thon, and M M Eibl
Intravenous gamma globulin therapy.
April 1982, Journal of clinical immunology,
J Litzman, and J Lokaj, and D Stikarovská, and J Mayer, and V Thon, and M M Eibl
Intravenous gamma-globulin therapy.
December 1996, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases,
J Litzman, and J Lokaj, and D Stikarovská, and J Mayer, and V Thon, and M M Eibl
[Intravenous gamma globulin therapy].
January 1976, Medicinski arhiv,
J Litzman, and J Lokaj, and D Stikarovská, and J Mayer, and V Thon, and M M Eibl
[Personal experience in intravenous narcoanalgesia with gamma-OH].
October 1966, Revista espanola de anestesiologia,
J Litzman, and J Lokaj, and D Stikarovská, and J Mayer, and V Thon, and M M Eibl
Gamma-globulin replacement therapy in immunodeficiency.
May 1987, Clinical immunology and immunopathology,
J Litzman, and J Lokaj, and D Stikarovská, and J Mayer, and V Thon, and M M Eibl
Replacement therapy with high dose intravenous gamma-globulin improves chronic sinopulmonary disease in patients with hypogammaglobulinemia.
May 1988, The Pediatric infectious disease journal,
J Litzman, and J Lokaj, and D Stikarovská, and J Mayer, and V Thon, and M M Eibl
Intravenous gamma-globulin therapy in bronchial asthma.
January 2002, Allergy and asthma proceedings,
J Litzman, and J Lokaj, and D Stikarovská, and J Mayer, and V Thon, and M M Eibl
Intravenous gamma-globulin therapy in immune thrombocytopenia.
March 1988, The Journal of pediatrics,
Copied contents to your clipboard!